DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation. (Q30357472)

20 June 2017

title

DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation. (English)

1 reference

20 June 2017

1

Jin Il Kim

1 reference

20 June 2017

Sehee Park

2

1 reference

20 June 2017

Sangmoo Lee

3

1 reference

20 June 2017

Ilseob Lee

4

1 reference

20 June 2017

Jun Heo

5

1 reference

20 June 2017

Min-Woong Hwang

6

1 reference

20 June 2017

Joon-Yong Bae

7

1 reference

20 June 2017

Donghwan Kim

8

1 reference

20 June 2017

Seok-Il Jang

9

1 reference

20 June 2017

Mee Sook Park

10

1 reference

20 June 2017

Man-Seong Park

11

1 reference

20 June 2017

publication date

19 December 2013

1 reference

The Journal of Microbiology

20 June 2017

published in

1 reference

20 June 2017

volume

51

1 reference

20 June 2017

issue

6

1 reference

20 June 2017

page(s)

866-871

1 reference

Early administration of oral oseltamivir increases the benefits of influenza treatment

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

The ferret as a model organism to study influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Animal Models for Influenza Virus Pathogenesis and Transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Immunization with live virus vaccine protects highly susceptible DBA/2J mice from lethal influenza A H1N1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Antivirals and resistance: influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

N-linked glycosylation in the hemagglutinin of influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

T-705 (favipiravir) activity against lethal H5N1 influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Replication and pathogenesis of the pandemic (H1N1) 2009 influenza virus in mammalian models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

The guinea pig as a transmission model for human influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Attenuation of the influenza virus sickness behavior in mice deficient in Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

The first influenza pandemic of the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Animal models in influenza vaccine testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Pharmacokinetics of high-dose oseltamivir in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Oseltamivir treatment of mice before or after mild influenza infection reduced cellular and cytokine inflammation in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Mutations in polymerase genes enhanced the virulence of 2009 pandemic H1N1 influenza virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12275-013-3428-7

Markers for predicting death as an outcome for mice used in infectious disease research.

21 January 2018

1 reference

12 December 2020

The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses

1 reference

12 December 2020

Early indicators of disease in ferrets infected with a high dose of avian influenza H5N1

1 reference

12 December 2020

Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071.

1 reference

12 December 2020

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

1 reference

12 December 2020

Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection

1 reference

12 December 2020

10.1007/S12275-013-3428-7

Identifiers

DOI

1 reference

20 June 2017

1 reference